James Gossage, M.D.

Job Title: 
Medical Director of Cure HHT
Department: 
Medicine
Treatments or Procedures Provided: 
Bevacizumab IV
Bevacizumab Topical
Genetic Counseling
Other AVM Treatment
Pre-Implantation Genetic Diagnostics
Conditions Treated: 
Anemia
Epistaxis
Inheritance
Intestinal bleeding
Intestinal telangiectasia
Liver AVM
Lung AVM
Nasal AVM
Oral AVM
Pregnancy
Language Spoken: 
English
Ages Treated: 
Infants (0-1 years)
Children (2-12 years)
Adolescents (13-17 years)
Adults (18 years or older)
1120 15th Street
BBR 5513
Augusta, GA 30912
United States
Scheduling Contact
phone: 
(706) 721-0470
Education & Facts
Number of HHT Patients: 
800 HHT Patients
Number of HHT conferences attended in past 3 years: 
3
Board Certification: 
American Board of Internal Medicine
Residency Program:
Barnes Hospital - 1987
Procedure History
Bevacizumab Topical: 
18
Bevacizumab IV: 
8
Biography: 
I have been interested in HHT since 1995 and opened an HHT Center in 2003. My areas of clinical and research interest include pulmonary AVM, pulmonary hypertension, right heart catheterization, and circulatory shock.
Last Updated: September 10, 2018
Go to top